Facet browsing currently unavailable
Page 4 of 672 results
Sort by: relevance publication year
Prediction models for hormone receptor status in female breast cancer do not extend to males: further evidence of sex-based disparity in breast cancer JOURNAL ARTICLE published 8 November 2023 in npj Breast Cancer Research funded by Scottish Funding Council (Saltire Emerging Researcher European Exchange Award) | Deutsche Krebshilfe (70113864) | Bundesministerium für Gesundheit (DEEP LIVERα,ZMVI1-2520DAT111) |
A functional genomic screen in vivo identifies CEACAM5 as a clinically relevant driver of breast cancer metastasis JOURNAL ARTICLE published 30 April 2018 in npj Breast Cancer |
Inflammatory breast cancer: a model for investigating cluster-based dissemination JOURNAL ARTICLE published 6 June 2017 in npj Breast Cancer |
Polygenic risk score for the prediction of breast cancer is related to lesser terminal duct lobular unit involution of the breast JOURNAL ARTICLE published 7 September 2020 in npj Breast Cancer Research funded by U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (1ZIACP010126,1ZIACP010126-23,1ZIACP010126,1ZIACP010126,1ZIACP010126,1ZIACP010126,1ZIACP010126,1ZIACP010126,1ZIACP010126,1ZIACP010126,1ZIACP010126,1ZIACP010126,1ZIACP010126) | U.S. Department of Health & Human Services | NIH | National Cancer Institute (U01 CA196383,U01 CA196383,U01 CA196383) |
Immunotherapy for early triple negative breast cancer: research agenda for the next decade JOURNAL ARTICLE published 18 February 2022 in npj Breast Cancer |
Current gene panels account for nearly all homologous recombination repair-associated multiple-case breast cancer families JOURNAL ARTICLE published 25 August 2021 in npj Breast Cancer Research funded by Cancer Research Society (OG-24377) |
Efficacy of platinum-based chemotherapy in metastatic breast cancer and HRD biomarkers: utility of exome sequencing JOURNAL ARTICLE published 4 March 2022 in npj Breast Cancer |
Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancer JOURNAL ARTICLE published 28 November 2018 in npj Breast Cancer |
The human intermediate prolactin receptor is a mammary proto-oncogene JOURNAL ARTICLE published 26 March 2021 in npj Breast Cancer Research funded by U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA173305) | U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (UL1TR002649) | Susan G. Komen (CCR19608826) |
ERα/PR crosstalk is altered in the context of the ERα Y537S mutation and contributes to endocrine therapy-resistant tumor proliferation JOURNAL ARTICLE published 30 November 2023 in npj Breast Cancer Research funded by U.S. Department of Health & Human Services | NIH | National Cancer Institute (5F31CA257634-02) |
Multi-center study on predicting breast cancer lymph node status from core needle biopsy specimens using multi-modal and multi-instance deep learning JOURNAL ARTICLE published 13 July 2023 in npj Breast Cancer |
Selective AKT kinase inhibitor capivasertib in combination with fulvestrant in PTEN-mutant ER-positive metastatic breast cancer JOURNAL ARTICLE published 16 April 2021 in npj Breast Cancer |
Spatial interplay of tissue hypoxia and T-cell regulation in ductal carcinoma in situ JOURNAL ARTICLE published 15 September 2022 in npj Breast Cancer |
TNF is a key cytokine mediating neutrophil cytotoxic activity in breast cancer patients JOURNAL ARTICLE published 20 April 2016 in npj Breast Cancer |
HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment JOURNAL ARTICLE published 20 May 2022 in npj Breast Cancer Research funded by Università degli Studi di Padova (BIRD 2019,BIRD 2020,BIRD 2020,BIRD-2019,BIRD 2019,BIRD 2020,DOR-2194859/21) | Associazione Italiana per la Ricerca sul Cancro (5 per mille ID. 22759 program,5 per mille ID. 22759 program) |
Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab JOURNAL ARTICLE published 22 March 2022 in npj Breast Cancer |
Extended adjuvant endocrine therapy in a longitudinal cohort of young breast cancer survivors JOURNAL ARTICLE published 25 April 2023 in npj Breast Cancer |
Prognostic characteristics in hormone receptor-positive advanced breast cancer and characterization of abemaciclib efficacy JOURNAL ARTICLE published 18 December 2018 in npj Breast Cancer |
TGFβ-mediated MMP13 secretion drives myoepithelial cell dependent breast cancer progression JOURNAL ARTICLE published 2 March 2023 in npj Breast Cancer Research funded by Cancer Research UK (C10847/A27781) | Breast Cancer Now (2017NovPR988) |
The deubiquitinating enzyme USP4 regulates BRCA1 stability and function JOURNAL ARTICLE published 11 May 2024 in npj Breast Cancer Research funded by National Natural Science Foundation of China (82172924,81972477,81772953) | National Science Foundation of China | Major Research Plan (2017YFA0503900) |